Ibnsina Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Ibnsina Pharma has a total shareholder equity of EGP1.8B and total debt of EGP15.7B, which brings its debt-to-equity ratio to 860.9%. Its total assets and total liabilities are EGP26.2B and EGP24.3B respectively. Ibnsina Pharma's EBIT is EGP1.8B making its interest coverage ratio 1.3. It has cash and short-term investments of EGP914.9M.
Key information
860.9%
Debt to equity ratio
ج.م15.69b
Debt
| Interest coverage ratio | 1.3x |
| Cash | ج.م914.94m |
| Equity | ج.م1.82b |
| Total liabilities | ج.م24.34b |
| Total assets | ج.م26.16b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ISPH's short term assets (EGP23.2B) exceed its short term liabilities (EGP23.1B).
Long Term Liabilities: ISPH's short term assets (EGP23.2B) exceed its long term liabilities (EGP1.2B).
Debt to Equity History and Analysis
Debt Level: ISPH's net debt to equity ratio (810.7%) is considered high.
Reducing Debt: ISPH's debt to equity ratio has increased from 126.1% to 860.9% over the past 5 years.
Debt Coverage: ISPH's debt is not well covered by operating cash flow (4.5%).
Interest Coverage: ISPH's interest payments on its debt are not well covered by EBIT (1.3x coverage).